[1] 唐俊舫, 徐丽艳, 朱允中等. 尿多酸肽联合NP与NP方案化疗在晚期非小细胞肺癌的随机对照临床研究[J]. 中国肺癌杂志, 2006, 9(6):536-539.[2] 王 彬, 汪 麟, 张湘茹等. 注射用紫杉肽治疗晚期恶性肿瘤Ⅰ期临床耐受性研究[J]. 中国新药杂志,2008, 18(12):1125-1129.[3] Maeshima Y, Colorado P C, Kalluri R. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties[J].J Biol Chem, 2000,275(31):23745-23750.[4] Kong Z L,Chiang L C,Fang F.Immune bioactivity in shellfish toward serum-free cultured human cell lines[J]. Bioscience Biotechnology and Biochemistry, 1997,61(1): 24-28[5] 许云禄,杨丽娟,刘广芬.舟山眼镜蛇毒细胞毒素的分离纯化及其体外抗肿瘤活性[J]. 中国生化药物杂志.2003, 24(3):127-130.[6] 周思朗, 屈艳妮, 张 健等. SR B法与M TT法细胞计数应用比较[J]. 中国现代医学杂志. 2005, 15(17):2615-2620.[7] 李祺福, 黄大川, 石松林等. 牡蛎低分子活性肽BPO-L对人肺腺癌A549细胞周期和相关癌基因、抑癌基因表达的调控作用[J]. 厦门大学学报(自然科学版). 2008, 47(1): 104-109.[8] 张静波. 细胞生物学实用方法与技术[M]. 北京:北京医科大学中国协和医科大学联合出版社,1996:209-211. [9] Dong W H, Xie Y H, Wang Z H. Apoptosis rate and objective diagnosis of drug resistance of ovarian cancer cell lines [J].The Chinese-German Journal of Clinical Oncology, 2005, 4(5):304-308.[10] Kaufmann S H, Lee S H, Meng X W, et al. Apoptosis-associated caspase activation assays[J]. Methods, 2008, 44(3):262-272.[11] Kuznetsov G, Tendyke K, Towle M J, et al. Tubulin-based antimitotic mechanism of E7974,a novel analogue of the marine sponge natural product hemiasterlin[J]. Mol Cancer Ther, 2009, 8(10):2852-2860.[12] Tardy C, Facompré M, Laine W, et al. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues[J]. Bioorg Med Chem, 2004, 12(7):1697-1701.[13] Assuncao G C, Linden R. Programmed cell deaths. Apoptosis and alternative deathsytle[J].Eur J Biochem, 2004, 271(9):1638-1650.[14] Degterev A, Boyce M, Yuan J. A decade of caspases[J].Oncogene, 2003, 22(53):8543-8567. [15] Wang J, Zheng L, Lobito A, et all. Inherited human caspase-10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymph proliferative syndrome type II[J], Cell, 1999, 98:47-58.[16] Thomas A, Fleisher M D, Oliveira M D. Autoimmune Lymph proliferative Syndrome[J]. IMAJ, 2005, 7:758–761. |